EUVIMEDEUVIMED entdecken
Crossref

Impact of new infusion drug HAES-LX-5% on the course of experimental toxic hepatitis

B. KONDRATSKYI, V. NOVAK, Ya. KONDRATSKYI, D. KACHMARYK, O. PANAS, M. VYNARCHYK, Yu. DERKACH

Experimental and Clinical Physiology and Biochemistry · 2015

DOI: 10.25040/ecpb2015.02.019 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Experimental and Clinical Physiology and Biochemistry, 2015. Verfasst von B. KONDRATSKYI und 6 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

KONDRATSKYI, B., NOVAK, V., KONDRATSKYI, Y., KACHMARYK, D., PANAS, O., VYNARCHYK, M., & DERKACH, Y. (2015). Impact of new infusion drug HAES-LX-5% on the course of experimental toxic hepatitis. Experimental and Clinical Physiology and Biochemistry. https://doi.org/10.25040/ecpb2015.02.019

Vancouver

KONDRATSKYI B, NOVAK V, KONDRATSKYI Y, KACHMARYK D, PANAS O, VYNARCHYK M, et al. Impact of new infusion drug HAES-LX-5% on the course of experimental toxic hepatitis. Experimental and Clinical Physiology and Biochemistry. 2015. doi:10.25040/ecpb2015.02.019

BibTeX
@article{KONDRATSKYI2015,
  author = {KONDRATSKYI, B. and NOVAK, V. and KONDRATSKYI, Ya. and KACHMARYK, D. and PANAS, O. and VYNARCHYK, M. and DERKACH, Yu.},
  title = {Impact of new infusion drug HAES-LX-5% on the course of experimental toxic hepatitis},
  journal = {Experimental and Clinical Physiology and Biochemistry},
  year = {2015},
  doi = {10.25040/ecpb2015.02.019}
}
Kostenlos starten →